Dilek Bayramgürler

Dilek Bayramgürler

Auto-generated profile, based on publicly available information

Dilek Bayramgürler

Department of Dermatology Kocaeli University Faculty of Medicine Kocaeli Turkey

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2015 in Current Neurovascular Research
Verified
Journal Article
Closed access
PDF file
TUTijen Utkan
Tijen Utkan
YYYusufhan Yazir
Yusufhan Yazir
AKAyse Karson
Ayse Karson
DBDilek Bayramgurler
Dilek Bayramgurler
Diabetes mellitus (DM) is related to an increase in the incidence of vascular dementia. Inflammation is an important cause of endothelial dysfunction and cognitive deficits. The anti -tumor necrosis factor (TNF)-α fusion protein etanercept has been reported to exhibit memory-enhancing effects and endothelial protection. We tested the effect of etanercept on the cognitive endpoints and compared it with the cognitive dysfunction in streptozotocin (STZ )- induced DM rats by using the Morris water maze test (MWMT) and passive avoidance test (PAT). Systolic blood pressure (SBP), thoracic endothelial function, endothelial nitric oxide synthase (eNOS) expression, and hippocampal brain-derived neurotrophic factor (BDNF) expression were assessed. Thirty days after the induction of DM, rats exhibited severe learning and memory deficits associated with endothelial dysfunction and decreased expression of eNOS and BDNF. Chronic treatment with etanercept (0.8 mg/kg, s.c., every week for 30 days) improved cognitive performance, endothelial function, and expression of eNOS and BDNF in DM rats. Furthermore, the memory-improving effects of etanercept were independent of hyperglycemia. These data suggest that etanercept treatment prevents changes in endothelial function, eNOS expression, and hippocampal expression of BDNF and, consequently, vascular dementia in DM rats.

1 June 2013 in European Journal of Pharmacology
Verified
Journal Article
Closed access
DBDilek Bayramgurler
Dilek Bayramgurler
AKAyse Karson
Ayse Karson
YYYusufhan Yazir
Yusufhan Yazir
ICIpek Komsuoglu Celikyurt
Ipek Komsuoglu Celikyurt
SKSema Kurnaz
Sema Kurnaz
TUTijen Utkan
Tijen Utkan

11 May 2024 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
FEFunda Erduran
Funda Erduran
EAEsra Adışen
Esra Adışen
YHYıldız Hayran
Yıldız Hayran
GAGüneş Gür Aksoy
Güneş Gür Aksoy
EAErkan Alpsoy
Erkan Alpsoy
AAAkın Aktaş
Akın Aktaş
Pyoderma Gangrenosum (PG) is a chronic disease characterized by recalcitrant skin ulcers. We aimed to evaluate the demographic, clinical characteristics, treatments and factors affecting the treatment responses of patients with PG. We performed a multicenter study of 12 tertiary care centers. We analyzed the data of the patients who were followed up with a diagnosis of PG between the years 2012‒2022 retrospectively. We included a total of 239 patients of whom 143 were female and 96 were male, with an average age of 54.2 ± 17.4 years. The most common treatment was systemic steroids (n = 181, 75.7%). Among these patients, 50.8% (n = 92) used systemic steroids as the sole systemic agent, while 49.2% (n = 89) used at least one adjuvant immunosuppressive agent. The independent factors determined in regression analysis to influence response to systemic steroids positively were disease onset age ≥ 30-years, negative pathergy, absence of leukocytosis, negative wound culture, presence of a single lesion, and absence of upper extremity involvement. Biological agents were used in 18.4% (n = 44) of the patients in the present study. We also analyzed pathergy positive PG and early onset (onset age < 30) PG separately due to their distinct clinical features which were revealed during statistical analysis. Retrospective nature of the present study. Analyses of the factors influencing treatment responses are addressed in this study. Also, we concluded that investigation for accompanying autoinflammatory diseases of pathergy positive PG and early onset PG is necessary and the patients in these two groups are more resistant to treatment, necessitating more complicated treatments.

23 May 2018
Verified
Book Chapter
Open access
PDF file
SKSelda Pelin Kartal
Selda Pelin Kartal
CACemile Tuğba Altunel
Cemile Tuğba Altunel
DBDilek Bayramgurler
Dilek Bayramgurler
Open access peer-reviewed chapter

1 October 2008 in Pediatric Neurology
Verified
Journal Article
Closed access
BKBülent Kara
Bülent Kara
NINagehan İnan
Nagehan İnan
DBDilek Bayramgürler
Dilek Bayramgürler
ÖAÖzgül Altıntaş
Özgül Altıntaş
AAAynur Akbulut
Aynur Akbulut

12 December 2023 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
PDF file
ADAbdullah Demirbaş
Abdullah Demirbaş
DBDi̇lEk Bayramgürler
Di̇lEk Bayramgürler
EYEmrah kagan Yasar
Emrah kagan Yasar
MAMuhammed Adak
Muhammed Adak
CDCan İlKer Demi̇r
Can İlKer Demi̇r
Background/aim: Human Demodex mites are parasites that live in the pilosebaceous unit and can cause demodicosis. While demodicosis may occur as a primary skin disease, it may also result from immunosuppression and topical or systemic immunosuppressive therapies. Surgical rhinoplasty is one of the most commonly performed cosmetic procedures, and it is the cause of a variety of cutaneous complications, particularly acne, as it affects the skin's adnexal structures. Thus, this study aimed to investigate whether the cutaneous changes in surgical rhinoplasty patients render them vulnerable to Demodex infestation. Materials and methods: Individuals who had undergone rhinoplasty (patients) and age- and sex-matched healthy volunteers (controls) were included in this prospective case-control study. To determine the Demodex density, samples were collected from the malar and nasal regions of both the patients and controls using the standard superficial skin biopsy method. Results: A total of 50 rhinoplasty patients and 50 healthy controls were enrolled in the study. The Demodex density on the nose was significantly higher in the rhinoplasty patients (p = 0.0001). Furthermore, the frequency of xerosis and pustules was significantly higher in the rhinoplasty patients compared to the control group (p = 0.046 and p = 0.001, respectively). Conclusion: Surgical rhinoplasty may be a risk factor for demodicosis, and patients will recover faster after surgery with proper diagnosis and treatment.